NCT02426307View on ClinicalTrials.gov

Subclinical Aortic Valve Bioprosthesis Thrombosis Assessed With 4D CT

Active, not recruitingOBSERVATIONAL
Enrollment

274

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

September 30, 2018

Study Completion Date

April 30, 2030

Conditions
Aortic Valve Stenosis
Interventions
PROCEDURE

TAVR

TAVR: Transcatheter Aortic Valve Replacement

PROCEDURE

SAVR

SAVR: surgical Aortic Valve Replacement

Trial Locations (1)

2100

Department of Cardiology and Radiology, Rigshospitalet, The Heart Center, Capital Region of Copenhagen, University of Copenhagen, Copenhagen

All Listed Sponsors
collaborator

Cedars-Sinai Medical Center

OTHER

lead

Rigshospitalet, Denmark

OTHER

NCT02426307 - Subclinical Aortic Valve Bioprosthesis Thrombosis Assessed With 4D CT | Biotech Hunter | Biotech Hunter